Follicle-stimulating hormone receptor (FSHR) N680S–genotyped women treated with either recombinant FSH or urinary FSH had higher pregnancy rates of 51% vs 40% in non-genotyped control individuals.
The synthesis of follicle-stimulating hormone (FSH) in pituitary gonadotrope cells is a tightly controlled process that integrates multiple endocrine and paracrine signals. Central to this regulation ...
Radionetics Oncology Inc. has discovered drugs targeting follicle-stimulating hormone (FSH) receptors reported to be useful for the diagnosis and treatment of cancer.
Glycosylation of gonadotropin hormones influences safety, efficacy, and immunogenicity. Currently approved recombinant FSH products are fully glycosylated, mirroring early preparations derived from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results